Labiotech article picture

May 06, 2021

Labiotech discussing our proactive approach 

Victor Kotsev has evaluated a broad range of initiatives following the COVID-19 pandemic. He also highlights Leyden Labs' proactive approach toward viral diseases amongst a range of vaccine and treatment options. To read the full article, click here

LL-Blue

OUR NEW APPROACH  |  OUR TEAM  |  JOIN OUR MISSION   |  NEWS  |  CAREERS  

Contact

Media inquiries

Stay updated

Leyden Laboratories B.V.

Leiden Laboratory
Emmy Noetherweg 2
2333 BK  Leiden
The Netherlands


© Leyden Labs, 2023  |  Privacy Statement  |  Design by Ape to Zebra

Back to top Arrow